Altium Capital Management LP Crinetics Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $5.05 Million - $7.3 Million	-197,000 Reduced 75.19%	65,000 $2.31 Million
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $2.03 Million - $3.88 Million	127,000 Added 94.07%	262,000 $7.79 Million
Q2 2023 Aug 14, 2023	BUY	$15.73 - $23.6 $550,550 - $826,000	35,000 Added 35.0%	135,000 $2.43 Million
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $1.53 Million - $2.11 Million	100,000 New	100,000 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$16.49 - $27.64 $3.36 Million - $5.64 Million	-204,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$17.15 - $28.31 $2.18 Million - $3.6 Million	-127,000 Reduced 38.37%	204,000 $4.48 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $2.67 Million - $3.92 Million	138,000 Added 71.5%	331,000 $9.4 Million
Q3 2021 Nov 17, 2021	SELL	$16.88 - $25.23 $3.88 Million - $5.8 Million	-230,000 Reduced 54.37%	193,000 $4.06 Million
Q3 2021 Nov 15, 2021	SELL	$16.88 - $25.23 $1.86 Million - $2.78 Million	-110,033 Reduced 20.64%	423,000 $11.3 Million
Q2 2021 Aug 13, 2021	BUY	$15.9 - $21.15 $2.72 Million - $3.62 Million	171,103 Added 47.28%	533,033 $10 Million
Q4 2020 Feb 16, 2021	BUY	$12.08 - $17.46 $4.37 Million - $6.32 Million	361,930 New	361,930 $5.11 Million

241

79.5M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.72B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.